Intelligence / Healthtech / New Clinical Trials / MIBIO PTE. LTD.
Clinicaltrial registered3 Nov 2026
MIBIO PTE. LTD.
3 Nov 2026: Trial registered · rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures.. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 3 Nov 2026
- Title
- rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures.
- Conditions
- Thrombocytopenia Associated With Chronic Liver Disease
- Phase
- Phase 3
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Georgia
- Country
- Georgia
- Reference
- NCT07911800
- Location
- Georgia
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at MIBIO PTE. LTD.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Georgia
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.